EGFR and lung carcinoma: Lung cancer is the leading cause of cancer death worldwide and in Taiwan.[1, 2] Today, a further understanding of the molecular mechanisms underlying non-small cell lung cancer (NSCLC) has resulted in the development of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs).